,000 mcg/ml by the presence of R factor. In the resistant strains showing MIC of 20,000 mcg/ml R factor did not exist and the resistance mechanism was reported to be due to the change of ribosomes.
The present authors tried to detect R factor from P. aeruginosa obtained from clinical specimens, and found R factors resistant to various drugs in about 10 per cent of the strains.3) Tetracycline (TC)-resistance mechanism of the strain having an R factor, kR102, resistant to five drugs among the above-described strains was reported previously. 4) This report deals with the mechanisms of drug resistance of highly SM-resistant strains showing MIC more than 51.200 mcg/ml.
Materials and Methods
Strains used3) : Table 1 (nalidixic acid resistance) and for the preparation of ribosomes, tryptone medium (Polypeptone 10 g, NaCl 8 g, yeast extract powder 1 g, glucose 1 g, 1 M CaCl2 2 ml; added after sterilization) was used.
Peptone water and nutrient agar (Eiken, Tokyo) were used for determination of MIC.
For spheroplast formation, medium B (normal medium, Eiken), medium BS (medium B containing 12 % sucrose) and medium BGS (medium BS containing 3 % glycine) were used. When using as solid media, 1.5 % agar was added to each medium. Reagents: SM of Meiji Seika Co., Ltd. was used. ATP (adenosine triphosphate), GTP (guanosine triphosphate), transfer RNA (t-RNA) from E. coli W, creatine phosphate, and creatine phosphokinase used in the experiments were all products of Sigma Chemicals Co. Phospho-(enol)pyruvate and 14C-L-valine (specific activity, 225 mCi/mmole) were obtained from Daiichi Pure Chemicals Co., Ltd., and ATP-?-32P (specific activity, 2.65 Ci/mmole) and ATP-8-14C (specific activity, 45 Ci/mmole) were obtained from the Radiochemical Centre, Amersham and from New England Nuclear, respectively. Drug resistance: MIC was determined according to the method reported previously,3) and drug resistance was represented by MIC. In some experiments multiplication of bacteria in liquid medium, K-BHI, was compared according to TREFFER'S method5): the resistance among strains was compared by means of ID50, the dose for 50 % inhibition of growth.
Preparation of cell-free extract: The extract was prepared according to the method of O'HARA et al.6) Protein content was determined by the method of LOWRY et al. 7) Inactivation of SM by cell-free extract: Three-tenth ml of the cell-free extract prepared to contain 30 mg protein/ml, 0.1 ml of 40 mM ATP, 0.1 ml of 1 mM SM, and 0.5 ml of TMK solution (0.1M tris-(hydroxymethyl)-aminomethane hydrochloride (Tris) buffer, pH 7.8, 0.06M KCl. 0.01 M magnesium acetate, 6 mM 2-mercaptoethanol) were mixed, and allowed to react at 37°C for 24 hours. After heating at 100°C for 3 minutes, the residual potency of SM was determined with B. subtilis PCI-219. Bioassay of SM in the culture: One-tenth ml of the overnight culture of each strain and 0.1 ml of 500 mcg/ml of SM were added to 0.8 ml of K-BHI, and after incubating at 37°C for 18 hours, the solution was heated at 100°C for 3 minutes, and centrifuged at 50,000×g for 15 minutes. The residual potency of SM in the supernatant thus obtained was determined by b ioassay.
Incorporation of amino acids: Phage f2 was isolated according to the method of GESTLAND,8) and RNA was extracted from the phage using the method of WEBSTER et al.9) S 100 fraction and ribosomes were prepared according to the method of MODOLELL et al.10) When crushing the bacteria, we added Bentonite (final concentration: 25 mg/ml) prepared by the method of FRAENKEL-CONRAT et al.11) as inhibitor of RNase activity and deoxycholate (final concentration: 0.5 %) for easy separation of ribosomes from the cell membrane. The composition of the reaction mixture is as follows: 60mM Tris buffer, pH 7.8; 30mM NH4Cl; 10mM Mg-acetate; l0 mM reduced glutathione; 3 mM ATP; 0.2 mM GTP; 10 mM phospho(enol)pyruvate; 5 mM creatine phosphate; 50mcg creatine phosphokinase/ml; 0.05mM each of the 19 amino acids; 0.03 mM 14C-valine; 0.1 mg of f2 RNA/ml; 1 mg t-RNA/ml; 0.2 volume of S 100 and ribosomal suspension (10 mg/ml). When addition of SM was required, it was kept at 37°C for 10 minutes during preincubation, and then f2 RNA and 14C-valine were added to initiate the reaction.
The reaction was performed at 34°C for 30 minutes: then 50µl of the reaction mixture was removed, and after adding 0.5 ml of cold trichloroacetic acid (TCA), the mixture was heated at 90°C for 15 minutes, and filtered through a membrane filter (Toyo Roshi, Co., Ltd.: TM-2. 0.42µ, size 13 m/m). After washing with 1 ml of 5 % TCA four times and drying, the filter was put in 10 ml of toluene based fluid and the radioactivity was determined by the liquid scintillation spectrometer. 
Results
As shown in Table 1 , according to the results of the comparison between the clinical isolates and the conjugant strains, it was presumed that K-Ps 94 would have R factor conferring high SM-resistance and KM-resistance, and that in K-Ps 97 the SM-resistance was nontransferable and possibly to be due to the control of the chromosomal gene. MIC of a conjugant strain, K-Ps 47 RFP (kR102), was 1,600 mcg/ml, which was obviously higher than that of K-Ps 47 RFP, 50 mcg/ml, but was lower than that of the original strain, K-Ps 102, more than 51,200 mcg/ml. Therefore, the SM-resistance of K-Ps 102 seemed to be due to the control of the resistance genes of R factor and chromosome.
As the mechanism of SM-resistance, inactivation due to SM-phosphorylating or adenylylating enzyme is known; it was investigated with ATP-?-32P and ATP-8-14C in this experiment. The results are shown in Table 2 .
As the degree of phosphorylation of SM was similar in K-Ps 94 and K-Ps 47 RFP (kR94), it was found that the mechanism of SM-resistance in K-Ps 94 was mainly owing to R factor controlling the production of SM-phosphorylating enzyme. It was also confirmed that in K-Ps 97, the production of adenylylating enzyme by SM-resistance gene on the chromosome would be the main mechanism of SM-resistance. It was, however, suggested that in K-Ps 102 SM-resistance might be due to some mechanism(s) other than SMinactivating enzyme.
It has been reported that spheroplasts of E. coli having R70 factor show a great increase of susceptibility to chloramphenicol (CP) as compared with intact cells of the same bacteria.13) The drug susceptibility of E. coli is reported to increase by EDTA treatment.14) In the experiment reported here, the concentration of EDTA was determined to be 0.5 mM, which allowed 30% growth of P. aeruginosa, and the susceptibilities to SM of various strains were compared. The SM susceptibility was represented by ID50 in Table 3 . The resistance due to R factor in K-Ps 102 could be evaluated based on the SM-resistance of K-Ps 47 RFP (kR102), as described above. In the conjugant, the susceptibility was obviously increased by EDTA treatment up to the level (23 mcg/ml) almost similar to ID50 of K-Ps 47 RFP, 12.5 mcg/ml. In the R factor-having strain, K-Ps 102, the susceptibility was obviously increased by EDTA treatment from ID50 of 19,000 to 800 mcg/ml. The difference of ID50 between intact cells and spheroplasts in both strains was due to the presence of R factor, kR 102, and the mechanism of SM-resistance of the R factor was revealed to be due to reduced permeability )2) studied SM-resistance in clinical isolates, and reported the strain which showed MIC of 20,000 mcg/ml but had no R factor.
The three highly resistant strains, which were found in our laboratory, showed MIC of more than 51,200 mcg of SM/ml: among them K-Ps 102 and K-Ps 94 had R factor conferring SM-resistance. These three highly resistant strains showed different genetic and biochemical resistance mechanisms: in K-Ps 94 the mechanism of SM-resistance was mainly due to the inactivating enzyme controlled by R factor (SM-phosphorylating enzyme), and in K-Ps 97 it was the SM-adenylylating enzyme by the resistance gene of chromosome.
In K-Ps 102 both the change of permeability (reduced permeability of the membrane) by the gene of R factor and the change of ribosome (reduced affinity to the drug) by chromosomal gene contribute to the mechanism of the high SM-resistance.
When R factor, kR94, found in K-Ps 94 (MIC: more than 51,200 mcg/ml) was transferred to K-Ps 47 RFP, it gave the resistance to SM of the same level and the degree of its inactivation was also similar.
However, the SM-phosphorylase activity of K-Ps 94 was merely about three times higher than that of K-Ps 61 (MIC: 6,400 mcg/ml) as shown in Tables 1 and 2, and its  susceptibility was reduced to about a half by EDTA treatment.
From the results, it is difficult to consider a certain relation between the MIC and the inactivating activity in K-Ps 94. Therefore, it was considered that R factor (kR94) would also affect the membrane permeability as well as the production of SM-phosphorylating enzyme. It was also considered that R factor (kR102) of K-Ps 102 did not affect production of inactivating enzyme but controlled decrease of the membrane permeability to give SM-resistance. Considering the fact, the presence of impermeability gene (imp) may be supposed on R factor. The resistance of K-Ps 79 (MIC: 1,600 mcg/ml) shown in Tables 1 and 2 was controlled by R factor (kR79), but inactivation could not be recognized: the level of resistance was similar to that of K-Ps 47 RFP (kR102). Consequently, kR79 may be considered to be similar to kR102. As to SM-resistance mechanism of bacteria having R factor (kR102), the change being susceptible to the drug by EDTA treatment was more remarkable than that by glycine treatment. Therefore, it was considered that cytoplasmic membrane would be more plausible resistance harrier than cell wall or outer layer of cell membrane.
As to the resistance mechanism other than drug-inactivation in P. aeruginosa, TANAKA15) also reported the ribosome resistance to gentamicin. K-Ps 102 used here was also ribosome resistant. The resistance of the strain may be considered to be further increased by R factor.
It will be noticed that some resistant strains, particularly of P. aeruginosa. are controlled genetically by R factor and chromosome, and it will present some problems in the further study on the resistance mechanism.
Though the development of novel drugs resistant to antibiotic inactivating enzyme is regarded as of major importance against drug resistant bacteria, a countermeasure should now be considered to overcome antibiotic resistant bacteria, the resistance mechanism of which is closely related to decreased permeability of cell membrane or low affinity of ribosome against antibiotics.
